|
|
Volumn 31, Issue 9, 2013, Pages 775-776
|
|
First Axl inhibitor enters clinical trials.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
AXL RECEPTOR TYROSINE KINASE;
MERTK PROTEIN, HUMAN;
ONCOPROTEIN;
PROTEIN KINASE INHIBITOR;
PROTEIN TYROSINE KINASE;
ANIMAL;
ANTAGONISTS AND INHIBITORS;
DRUG INDUSTRY;
HUMAN;
KNOCKOUT MOUSE;
MEDICAL RESEARCH;
MOUSE;
NEOPLASMS;
PHYSIOLOGY;
ANIMALS;
ANTINEOPLASTIC AGENTS;
BIOMEDICAL RESEARCH;
DRUG INDUSTRY;
HUMANS;
MICE;
MICE, KNOCKOUT;
NEOPLASMS;
PROTEIN KINASE INHIBITORS;
PROTO-ONCOGENE PROTEINS;
RECEPTOR PROTEIN-TYROSINE KINASES;
|
|
EID: 84892438921
PISSN: None
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt0913-775a Document Type: Note |
|
Times cited : (92)
|
|
References (0)
|
